ArticleBMC health services research2026
Feasibility of mainstreaming schistosomiasis and soil transmitted helminthiasis mass drug administration into primary healthcare: a baseline survey for a community case study in Western Kenya.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07507461 (Protocol for a Community Case Study on Integrating Schistosomiasis and Soil-Transmitted Helminthiasis Mass Drug Administration Into Primary Health Care in Western Kenya), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Protocol for a Community Case Study on Integrating Schistosomiasis and Soil-Transmitted Helminthiasis Mass Drug Administration Into Primary Health Care in Western Kenya
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMass drug administration campaigns have enabled great progress in the prevention and control of schistosomiasis and soil transmitted helminthiasis. However, the persistence of these infections continues to challenge public health systems despite decades of control efforts. This study was commissioned to evaluate the feasibility of a transition from periodic mass drug administration campaigns to a sustainable, facility- and community-based delivery model in Western Kenya.
methodsThe study is part of a non-randomized, controlled before-and-after study using a mixed-methods approach. Data were collected from 1,229 households, 24 health facilities (12 control, 12 intervention), focus group discussions, and key informant interviews. The analysis focused on six domains of mainstreaming feasibility: perception of mainstreaming among key stakeholders, processes, infrastructure and system readiness, acceptability and trust for primary healthcare-led treatment, facilitators, and barriers. Finally, we calculated a composite readiness index to grade facility readiness.
resultsGenerally, community perceptions to schistosomiasis and soil-transmitted helminthiasis treatment benefits were found to be high in both the control and intervention groups. Qualitative data showed enhanced trust in the integrated model by virtue of the credibility and professional nature of health facility staff. An overwhelming majority of community members received treatment through household visits (95.5%) implying reliance on periodic MDA at baseline. Community Health Promoters remain a critical source of information on treatment opportunities for low-literacy populations, while media and health facilities are increasingly important among more educated groups. We also found high infrastructural and systemic readiness for treatment mainstreaming with respect to stock availability and data reporting systems. However, stock outs were reported among the facilities. High variability in health worker training coverage suggests a critical challenge in workforce preparedness.
conclusionThe findings point to a strong foundation for mainstreaming but underscore the need for a structured implementation package. Priority actions should include standardized operating procedures, supply chain and digital system strengthening, and expanded Community Health Promoter-led outreach activities to improve consistency, access, and sustainability of deworming services within primary healthcare platforms.
trial registrationRegistration number NCT07507461, prospectively registered on 28th January, 2026.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.